Veeva Systems Inc. $VEEV Shares Sold by Calamos Wealth Management LLC

Calamos Wealth Management LLC cut its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 11.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 16,770 shares of the technology company’s stock after selling 2,255 shares during the quarter. Calamos Wealth Management LLC’s holdings in Veeva Systems were worth $4,787,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Compass Financial Management LLC acquired a new position in Veeva Systems in the second quarter valued at $27,000. Burkett Financial Services LLC bought a new position in Veeva Systems during the third quarter worth $27,000. Farmers & Merchants Investments Inc. lifted its holdings in Veeva Systems by 181.8% in the third quarter. Farmers & Merchants Investments Inc. now owns 93 shares of the technology company’s stock worth $27,000 after acquiring an additional 60 shares during the last quarter. Arlington Trust Co LLC acquired a new stake in shares of Veeva Systems in the second quarter valued at approximately $29,000. Finally, Field & Main Bank bought a new stake in shares of Veeva Systems during the second quarter valued at about $29,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Guggenheim boosted their target price on shares of Veeva Systems from $276.00 to $310.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Barclays upped their price target on Veeva Systems from $360.00 to $375.00 and gave the stock an “overweight” rating in a report on Wednesday, October 28th. BMO Capital Markets upped their price target on Veeva Systems from $175.00 to $270.00 and gave the company a “market perform” rating in a report on Thursday, August 27th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $330.00 price objective (up from $320.00) on shares of Veeva Systems in a report on Tuesday, September 8th. Finally, Robert W. Baird raised their price objective on shares of Veeva Systems from $300.00 to $350.00 and gave the stock an “outperform” rating in a report on Monday, October 26th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $309.08.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Royal Bank of Canada raised its price target to $365 from $325 and reiterated an “outperform” rating, implying about 20% upside from the cited $304.23 share price. Royal Bank of Canada recommendations
• Positive Sentiment: Needham raised its target to $360 from $310 and maintained a “buy” rating, citing about 18% potential upside from $304.23. Needham recommendations
• Positive Sentiment: Stifel lifted its price target to $340 from $300, adding to the wave of upward target revisions. Stifel raises Veeva price target
• Positive Sentiment: UCB selected Veeva Vault CRM as a core platform for its commercial operations and plans to use industry-specific AI for product launches and customer engagement. The deal supports Veeva’s positioning as a specialized technology provider for life sciences companies. Veeva becomes core CRM choice for major biopharma AI rollout

Insider Transactions at Veeva Systems

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $261.04, for a total value of $195,780.00. Following the sale, the director directly owned 3,242 shares in the company, valued at approximately $846,291.68. The trade was a 18.79% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas D. Schwenger sold 10,000 shares of the business’s stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the sale, the insider directly owned 19,449 shares in the company, valued at $5,471,587.17. This trade represents a 33.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 56,789 shares of company stock worth $14,913,889. 10.60% of the stock is currently owned by insiders.

Veeva Systems Price Performance

VEEV traded down $5.87 during trading on Friday, reaching $304.23. The company had a trading volume of 1,746,403 shares, compared to its average volume of 1,508,434. The business’s fifty day moving average price is $289.24 and its 200 day moving average price is $211.95. Veeva Systems Inc. has a 12 month low of $148.05 and a 12 month high of $325.99. The company has a market cap of $49.26 billion, a P/E ratio of 50.04, a PEG ratio of 1.31 and a beta of 0.89.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.23 by $0.12. The business had revenue of $927.96 million for the quarter, compared to analysts’ expectations of $905.38 million. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The firm’s revenue was up 17.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, sell-side analysts predict that Veeva Systems Inc. will post 6.70 EPS for the current fiscal year.

Veeva Systems Company Profile

Veeva Systems Inc develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations.

The company’s products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.

Founded in 2007 and headquartered in Pleasanton, California, Veeva serves life sciences companies in markets around the world.